Casdin Eli

Average Profitability
<0.0001%
Insider Buys Quantity
9
Insider Buys Sum
$137.61M
Insider Sells Quantity
2
Insider Sells Sum
$18.44M

Insider Activity of Casdin Eli

The largest purchase of all time was on 2022-04-29 and amounted to 11437500 shares of GeneDx Holdings Corp. for $45.75M.

The largest sale of all time was on 2022-07-01 and amounted to 3235548 shares of MaxCyte, Inc. for $13.91M.

Biography of Casdin Eli

No biography is available at this moment.

2023-05-19PurchaseStandard BioTools Inc.
LAB
800,000
0.268%
$2.29$1.84M+5.02%
2023-05-18PurchaseStandard BioTools Inc.
LAB
150,000
0.0473%
$2.16$323,865+9.59%
2023-05-17PurchaseStandard BioTools Inc.
LAB
250,000
0.0688%
$1.89$471,550+23.08%
2023-01-31PurchaseGeneDx Holdings Corp.
WGS
85.71M
1.3931%
$0.35$30M-58.45%
2022-11-17PurchaseTenaya Therapeutics, Inc.
TNYA
director
2.49M
5.7821%
$2.60$6.48M+22.2%
2022-10-03SaleMaxCyte, Inc.
MXCT
director
735,786
0.6357%
$6.15$4.53M
2022-07-01SaleMaxCyte, Inc.
MXCT
3.24M
2.9263%
$4.30$13.91M+12.21%
2022-04-29PurchaseGeneDx Holdings Corp.
WGS
11.44M
2.1245%
$4.00$45.75M-58.25%
2021-08-03PurchaseTenaya Therapeutics, Inc.
TNYA
850,000
2.6033%
$15.00$12.75M-27.98%
2021-07-26PurchaseAbsci Corporation
ABSI
director
1.56M
1.4521%
$16.00$25M-63.43%
2021-06-22PurchaseCentury Therapeutics, Inc.
IPSC
director
750,000
4.8121%
$20.00$15M-41%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.